Objective: To determine whether current-generation endoluminal ultrasonic transducer technology could visualize dysplastic and malignant cervical lesions.
Methods: Inclusion criteria for patients enlisted in the study were abnormal Papanicolaou test results, an abnormality seen at colposcopy, and consent for a cone biopsy. In addition, we included 4 women who were undergoing hysterectomy but had no evidence of cervical abnormalities at the time of surgery, for a total of 28 women. We used a 20-MHz annular array intravascular transducer. We correlated all sonographic and pathologic results with regard to being normal or abnormal using the Pearson product moment correlation coefficient, and we evaluated interobserver variation by having 5 blinded sonologists interpret each examination and calculating kappa statistics.
Results: We performed intracervical sonography on 24 women with abnormal Papanicolaou test results and on 4 women without abnormalities. Nineteen of the 24 women with proven disease had abnormal sonographic images. Five women with pathologically proven cervical intraepithelial neoplasia I had normal sonographic images. Lesions ranged in size from 0.3 to 7 mm. Two carcinomas (5 and 7 mm diameter), multiple nabothian cysts, cervicitis, and 2 giant cell foreign body reactions were visible on sonography. The correlation coefficient for abnormal sonographic and pathologic findings was 0.87 (P < .005). We obtained a kappa value of 0.75 for interobserver variation.
Conclusions: Intracervical sonography was able to visualize dysplastic lesions and carcinomas as hypoechoic defects with surrounding echogenic areas of glandular cervical mucosa. Lesions were shown with sufficient resolution and interobserver variation to suggest that the technique may be clinically applicable, particularly for planning surgical therapy. However, design of a transducer that can be easily sterilized between examinations, similar to current endovaginal probes, would be necessary to make intracervical sonography a clinically feasible examination.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.7863/jum.2003.22.1.61 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Prenatal identification of invasive placentation using ultrasound in women with placenta previa and prior cesarean delivery.
Eur J Obstet Gynecol Reprod Biol
November 2024
Department of Neuroscience, Reproductive Sciences and Dentistry, School of Medicine, University of Naples Federico II, Naples, Italy.
Article Synopsis
- The study aimed to evaluate how effective ultrasound is in detecting invasive placentation in women with placenta previa who have a history of cesarean delivery.
- It involved a multicenter, retrospective analysis of 180 singleton pregnancies at risk for placenta accreta between January 2010 and May 2020, focusing on women with diagnosed placenta previa.
- Out of 155 women suspected to have placenta accreta based on ultrasound findings, 99 were confirmed to have the condition during delivery, highlighting the ultrasound's diagnostic potential.
The sonographic assessment to diagnose Placenta Accreta Spectrum disorders: "Riddled Cervix" and other signs.
Arch Gynecol Obstet
August 2024
Obstetrics and Gynaecology Unit, Department of Biomedical Sciences and Human Oncology, University of Bari "Aldo Moro", Piazza Giulio Cesare 11, 70124, Bari, Italy.
Transabdominal and transvaginal ultrasound findings help to guide the clinical management of placenta accreta spectrum cases.
Acta Obstet Gynecol Scand
January 2024
Department of Obstetrics and Gynecology, Dr. Soetomo Academic General Hospital, Universitas Airlangga, Surabaya, Indonesia.
Introduction: The clinical management of placenta accreta spectrum (PAS) depends on placental topography and vascular involvement. Our aim was to determine whether transabdominal and transvaginal ultrasound signs can predict PAS management.
Material And Methods: We conducted a retrospective cohort study of consecutive prenatally suspected PAS cases in a single tertiary-care PAS center between January 2021 and July 2022.
Ultrasound-guided repositioning technique for partially expelled intrauterine device: descriptive feasibility study.
Ultrasound Obstet Gynecol
January 2023
Department of Gynecology and Obstetrics, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil.
Objective: To describe the feasibility of an ultrasound-guided repositioning technique for partially expelled intrauterine devices (IUDs) without use of sedation.
Methods: This was a descriptive feasibility study of patients with a partially expelled IUD managed in our outpatient clinic from January 2016 to February 2020. The partially expelled IUDs (vertical arm extending partially or entirely through the cervical canal) were repositioned at the uterine fundus using Hartmann alligator forceps under ultrasound guidance.
Transvaginal Sonographic Assessment Following Cervical Pessary Placement for Preterm Birth Prevention.
AJP Rep
January 2022
Department of Obstetrics and Gynecology, TriHealth-Good Samaritan Hospital, Cincinnati, Ohio.
Transvaginal sonographic cervical length assessment identifies pregnant women at risk for preterm birth, and the subsequent placement of a cervical pessary may reduce this risk. The mechanism of action remains uncertain, and postplacement transvaginal sonography may provide further insight into the controversial efficacy of this therapy. To identify any pre- or postplacement sonographic findings associated with preterm delivery following cervical pessary insertion among at-risk women.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!